Conjunctivitis, Bacterial Clinical Trial
— MACHOOfficial title:
Microbiologic Alterations of the Conjunctiva of Hot Tub-soaking Ophthalmologists
NCT number | NCT03987178 |
Other study ID # | 18-26141 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 27, 2019 |
Est. completion date | March 26, 2020 |
Verified date | September 2020 |
Source | University of California, San Francisco |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine if there are microbiologic alterations of the ocular surface after hot tub exposure. The study will evaluate the number of microbes before and after hot tub use in order to find out whether hot tub exposure has any change on the organisms present on the ocular surface. Participants will be randomized to dunk or not to dunk their head during their time in the hot tub.
Status | Completed |
Enrollment | 36 |
Est. completion date | March 26, 2020 |
Est. primary completion date | March 26, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria: - greater of 18 years of age - a willing participant - healthy Exclusion criteria: - pregnancy - high or low blood pressure - active diarrhea - lymphedema - heart disease - seizure disorder. |
Country | Name | City | State |
---|---|---|---|
United States | UCSF | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quantity of organisms | Genus-species will be identified for each sample, and quantified with an ordinal scale (0-4). The total of this score will be the quantity for that person-time. The primary analyses will be a Wilcoxon Rank Sum test (Mann-Whitney) between the two arms at the follow-up time point (randomized comparison of dunk vs no-dunk), and a Wilcoxon Signed Rank test between pre-hot-tub and post-hot-tub (longitudinal comparison of all cases). We estimate that a total of 20 subjects will provide 80% power to detect a 1.25 SD difference in the total quantity score between randomization arms at the post (f/u) time point. We estimate 80% power to detect a .9 SD difference between pre (baseline) and post (f/u) time points in a paired longitudinal analysis. |
1 year | |
Secondary | Richness (number of species per sample) of organisms found in the conjunctiva with hot tub use (post-test comparison) | The investigators will assess whether organism diversity (richness) changes between arms (post-test comparison) using Simpson's Diversity, expressed in units of effective number (see Jost). We will also assess using Shannon's Diversity. | 1 year | |
Secondary | Richness (number of species per sample) of organisms found in the conjunctiva with hot tub use (pre versus post) | The investigators will assess whether organism diversity (richness) changes longitudinally (pre vs post-test comparison). | 1 year | |
Secondary | Difference in organism profile with hot tub use (pre versus post) | The investigators will determine whether the organism profile differs longitudinally (pre vs post-test comparison) using L-2 norm (Euclidean distance) and PERMANOVA. We will also assess using L-1 norm (Manhattan distance) | 1 year | |
Secondary | Difference in organism profile with hot tub use (between arms) | The investigators will determine whether the organism profile differs between arms (post-test comparison) using L-2 norm (Euclidean distance) and PERMANOVA. We will also assess using L-1 norm (Manhattan distance) | 1 year | |
Secondary | Quantity comparing pre-hot tub and post-hot tub swabs | We will compare quantity of organisms (amount and type) before and after hot tub use in both arms. We will used a paired t-test for analysis. | 1 year | |
Secondary | Specific organisms found in the conjunctiva with hot tub use | The investigators will compare specific organisms (Staphylococcus epidermidis, Corynebacterium species) between arms (post-test only) and longitudinally between time points (pre vs post-test) with Bonferroni correction | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00407589 -
Systemic Pharmacokinetics of BOL-303224-A
|
Phase 1 | |
Terminated |
NCT03696342 -
Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.
|
Phase 3 | |
Withdrawn |
NCT03698045 -
Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.
|
Phase 1 | |
Completed |
NCT00357773 -
Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis
|
Phase 3 | |
Completed |
NCT03519516 -
Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects
|
Phase 1 | |
Withdrawn |
NCT01721694 -
Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
|
Phase 3 |